Xbrane Biopharma AB (XBRANE.ST) Q3 2026 Earnings

17JulConfirmed
Q2 2025
Q3 2025
Q4 2025
Q3 2026
-1.16
3.85
8.87
13.89

Details

Expected EPS
-0.5347759482
Actual EPS
N/A
Surprise EPS
0.53
Surprise Percent
+100%

Description

Xbrane Biopharma AB (XBRANE.ST) will report earnings of for Q3 2026 on July 17, 2026.

0 Comments

Share your thoughts